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Activation of Phospholipase C Increases Intramembrane
Electric Fields in N1E-115 Neuroblastoma Cells
Chang Xu and Leslie M. Loew
Department of Physiology and Center for Biomedical Imaging Technology, University of Connecticut Health Center,
Farmington, Connecticut 06030
ABSTRACT We imaged the intramembrane potential (a combination of transmembrane, surface, and dipole potential) on
N1E-115 neuroblastoma cells with a voltage-sensitive dye. After activation of the B2 bradykinin receptor, the electric ﬁeld
sensed by the dye increased by an amount equivalent to a depolarization of 83 mV. The increase in intramembrane potential
was blocked by the phospholipase C (PLC) inhibitors U-73122 and neomycin, and was invariably accompanied by a transient
rise of [Ca21]i. A depolarized inner surface potential, as the membrane loses negative charges via phosphatidylinositol 4,5-
bisphosphate (PIP2) hydrolysis, and an increase in the dipole potential, as PIP2 is hydrolyzed to 1,2-diacylglycerol (DAG), can
each account for a small portion of the change in intramembrane potential. The primary contribution to the measured change in
intramembrane potential may arise from an increased dipole potential, as DAG molecules are generated from hydrolysis of
other phospholipids. We found bradykinin produced an inhibition of a M-type voltage-dependent K1 current (IK(M)). This
inhibition was also blocked by the PLC inhibitors and had similar kinetics as the bradykinin-induced modulation of
intramembrane potential. Our results suggest that the change in the local intramembrane potential induced by bradykinin may
play a role in mediating the IK(M) inhibition.
INTRODUCTION
Although the behavior of the voltage-gated ion channels in
cell membranes is physiologically modulated by the trans-
membrane potential, the regulatory elements in the channels
(e.g., gating charges) are fundamentally responding to the
electric ﬁeld within the plasma membrane—the intramem-
brane electric ﬁeld, which is generated by a complicated sum
of transmembrane potential, surface potential, and dipole
potential (for reviews, see Honig et al., 1986; Loew, 1993).
Surface potential is the electric potential difference between
the membrane-aqueous interface and the bulk aqueous
solutions (for reviews, see McLaughlin, 1977, 1989). The
difference between the negative surface potential on the
outer and inner surfaces of a cell membrane contributes to
the intramembrane electric ﬁeld. Cell membranes also
possess a substantial dipole potential arising from the ori-
ented dipoles of lipid ester groups or immobilized water
molecules at the membrane-water interface (Szabo, 1974,
1977; Clarke, 1997; Flewelling and Hubbell, 1986; Franklin
and Caﬁso, 1993; Gawrisch et al., 1992; Zheng and
Vanderkooi, 1992). This potential is on the order of several
hundred mVs, positive in the interior of the membrane. Like
transmembrane potential, membrane surface potential
(Chandler et al., 1965; Gilbert and Ehrenstein, 1969;
McLaughlin, 1989) can modulate the activity of voltage-
dependent ion channels by changing the intramembrane
electric ﬁeld. The effect of dipole potential on ion channel
activity is less well studied. However, there is evidence
indicating that modulators of dipole potential such as
phloretin and cholesterol do affect the potassium current in
the squid giant axon (Strichartz et al., 1980) and voltage-
dependent calcium channels in several cell types (Locher
et al., 1984; Zhou et al., 1991; Sen et al., 1992). In dif-
ferentiated N1E-115 cells, it has been found in this lab that
the voltage-gated sodium channels of the growth cone have
a faster activation rate than those in the soma (Zhang et al.,
1996), possibly because the growth cone region has a more
positive dipole potential than the soma membrane (Bedlack
et al., 1994).
Whether the activation of membrane receptors can
modulate intramembrane potential, especially surface poten-
tial and dipole potential, has not been investigated, perhaps
because appropriate methods for monitoring the intramem-
brane potential in cells have not been well established. In
particular, we are interested in the possible change in intra-
membrane potential after receptor activation of phospho-
lipase C (PLC). Activation of PLC leads to hydrolysis of
phosphatidylinositol 4,5-bisphosphate (PIP2) to the second
messengers, diacylglycerol and inositol 1,4,5-trisphosphate
(IP3) (Berridge, 1993). Whereas IP3 causes Ca
21 release
from intracellular Ca21 stores by activating IP3 receptors,
diacylglycerol activates protein kinase C (PKC) thereby
modulating a wide range of cellular responses. Recently, it
has been suggested that changes in PIP2 concentration could
play an important role in regulating cellular processes (Lee
and Rhee, 1995). The anionic PIP2 comprises 0.1%–5% of
total lipids in the inner leaﬂet of the membrane of most cells
(Kleinig, 1970; Tran et al., 1993). We hypothesize that the
surface potential and dipole potential proﬁle of the mem-
brane may be changed after hydrolysis of PIP2 based on the
following two ﬁndings: ﬁrst, a decrease in PIP2 concen-
tration could lead to a change in the surface potential
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(McLaughlin, 1989); secondly, generation of 1,2-diacylgly-
cerol (DAG) from phosphatidylinositol could increase dipole
potential, since the dipole potential of a DAG monolayer is
127 mV more positive compared to that of a phosphatidyli-
nositol monolayer (Smaby and Brockman, 1990).
Such intramembrane potentials are impossible to measure
using conventional electrodes placed in the bulk solutions,
since the surface potentials arising from the negative charges
on both surfaces of the plasmalemma decay with a Debye
length of under 10 A˚ in 0.1 M monovalent salt solutions
(McLaughlin, 1989; Cevc, 1990; Langner et al., 1990), and
the dipole potentials are localized to an ;5 A˚ thick region
within the plasmalemma just below both surfaces (Szabo,
1974, 1977; Clarke, 1997; Flewelling and Hubbell, 1986;
Franklin and Caﬁso, 1993; Gawrisch et al., 1992; Zheng and
Vanderkooi, 1992). However, certain voltage-sensitive dyes
can report the local electric ﬁeld at their location within the
membrane. We have shown that the dual wavelength ratio of
styryl dyes provides a consistent measure of transmembrane
potential (Montana et al., 1989; Zhang et al., 1998). In earlier
studies, others and we characterized the ability of di-8-
ANEPPS to measure dipole potential changes and variations
along the membrane (Bedlack et al., 1994; Cladera and
O’Shea, 1998; Clarke, 1997; Clarke and Kane, 1997; Gross
et al., 1994). In a recent study (Xu and Loew, 2003), we
showed that the styryl dye ratiometric measurements could
be used to monitor changes in surface potential.
In this paper, dual wavelength ratiometric imaging of
di-8-ANEPPS was used to determine the change in the intra-
membrane potential of a cell during receptor-mediated acti-
vation of the PLC signaling pathway. We used bradykinin
(BK) to activate PLC in N1E-115 neuroblastoma cells, a
mouse neuroblastoma cell line that expresses a number of
G-protein-coupled receptors, including B2 receptors (Cog-
gan and Thompson, 1995; 1997). BK has also been shown to
modulate the M current in these cells, but the mechanism of
this modulation remains unclear (Higashida and Brown,
1987). The dye ratio reports a large slow change in intra-
membrane potential that has the same time course as the
modulation of the M current by B2 receptor activation in
these cells. Because IK(M) has been described as a voltage-
dependent K1 current (Constanti and Brown,1981; Brown
and Constanti, 1980), this raises the possibility that changes
in intramembrane potential may underlie the modulation of
IK(M).
METHODS
Cell preparation
N1E-115 mouse neuroblastoma cells were grown and maintained in
Dulbecco’s modiﬁed Eagle’s medium containing 10% fetal bovine serum.
Cells were grown until 50% conﬂuent before seeding on uncoated glass
coverslip. Differentiation was initiated by replacing the media with one
containing 0.5% fetal bovine serum and 1% dimethylsulfoxide. Cells were
cultured for a further 2–5 days to complete differentiation and achieve
neuronal morphology.
Dye loading
For di-8-ANEPPS staining, each coverslip was washed in Eagle’s balanced
salt solution (EBSS) buffered to pH 7.35 with 20 mM HEPES, and then
incubated for 20 min at 48C in the buffered EBSS supplemented with 1-(3-
sulfonatopropyl)-4-[b[2-(di-n-octylamino)-6-naphthyl]vinyl]pyridinium be-
taine (di-8-ANEPPS; 0.5 mM) and Pluronic F-127 (BASF, Wyandotte, MI)
(PF-127;0.05%). For double staining with Calcium Green and di-8-
ANEPPS, Calcium Green-1-AM (Molecular Probes, Eugene, OR) was
diluted to 8 mM in 2 ml EBSS. A single coverslip of cells was immediately
added, incubated 30 min at 22–258C in the dark, and then transferred to fresh
EBSS to allow recovery at 378C for 30 min. The cells were then transferred
and incubated in the 48C buffered EBSS containing di-8-ANEPPS and
Pluronic F-127 for another 20 min.
Dual wavelength imaging
Stained cells were mounted on an inverted Zeiss microscope (Axiovert 135
TV) and viewed with an oil objective (Plan-Apochromat 63 3 1.40). Dual
wavelength image pairs of di-8-ANEPPS (excitation at 440 and 530 nm,
emission [570 nm) were acquired using a cooled CCD camera (Model
CH100, Photometrics, Tucson, AZ) on the microscope, controlled by
Cellscan Acquisition Control unit (Scanalytics, Marlborough, MA). An
additional magniﬁcation of 32.5 was used when ﬂuorescent images were
taken. Exposure time was 0.7 s for 440 nm and 1.4 s for 530 nm. A 2 3 2
binning of CCD pixels was used to improve the signal. Autoﬂuorescence
signals were negligible at both excitation wavelengths compared with di-8-
ANEPPS ﬂuorescence. All experiments were performed at room temper-
ature (22–248C). For cells that were double labeled for simultaneous calcium
and membrane potential imaging, di-8-ANEPPS ﬂuorescence was excited at
440 and 530 nm and detected at [570 nm, whereas Calcium Green
ﬂuorescence was excited at 485 nm and detected at 525 nm.
Patch clamp
Micropipettes with tip diameters of 1–2 mm were pulled from glass
capillaries (Drummond Scientiﬁc 100) using a Model P-80 Brown-Flaming
micropipette puller (Sutter Instrument, San Francisco, CA). The resistance
of the pipettes was from 3 to 7 MV. The patch pipette solution contained (in
mM): 80 potassium acetate, 30 KCl, 3 MgCl2, 3 EGTA, 40 HEPES, 1 CaCl2
(PH 7.3 with KOH). The whole-cell patch experiments were performed in
N1E-115 neuroblastoma cells with an Axopatch 1D ampliﬁer (Axon
Instruments, Foster City, CA). All electrophysiological recordings were
performed at room temperature (22–248C). Whole-cell current clamp was
used to monitor membrane potential. We digitized the output signal by using
the Clampex program (Axon Instruments).
Lipid vesicles
Solutions were buffered with 20 mM HEPES/Tris, pH 7.0 (218C), and
contained 140 mM NaCl in the absence of any divalent salts. Small
unilamellar liposomes were made as described by Deamer and Uster (1983).
Brieﬂy, we prepared the lipid vesicles by drying chloroform solutions of
either 10 mg egg phosphatidylcholine (PC) (Sigma Chemical, St Louis, MO;
type XI-E), or bovine brain phosphatidylserine (PS) (Avanti Polar Lipids,
Birmingham, AL), or a mixture of 90% PC and 10% 1-palmitoyl-2-oleoyl-
sn-glycerol (Avanti Polar Lipids) (PC:DAG), or a mixture of 90% PS and
10% 1-palmitoyl-2-oleoyl-sn-glycerol (PS:DAG), under a stream of argon
for a minimum of 3 h, resuspending the lipids in 1 ml of the buffer and
sonicating to clarity with a Laboratory Supplies (Hicksville, NY) G1128P1T
soniﬁer under an argon atmosphere. For ﬂuorescence measurements, 60 ml
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of the vesicle suspension was diluted into 3 ml of buffer containing 0.2 mM
di-4-ANEPPS. The corrected excitation spectra of the vesicle suspension
were measured with a SPEX CM dual-wavelength ﬂuorescence spectrom-
eter (SPEX Industries, Edison, NJ). All experiments were performed at 218C.
[32P]PIP2 analysis
To examine the relative PIP2 content of membrane, N1E-115 cells were
grown to 30–40% conﬂuency in 35 mm culture dishes; ;4 3 105 cells per
culture dish were labeled to equilibrium (48 h) with 25 mCi/ml 32P-PO4
(carrier free, ICN) at 378 in EBSS. After washing twice to remove the
unincorporated 32P, the cells were scraped and suspended with EBSS. Cell
lipids were extracted with acidic chloroform-methanol as described
previously (Agranoff et al., 1983). An aliquot (20 ml) of the lipid extract
was subjected to thin layer chromatography (TLC), using Whatman LK5D
plates impregnated with 1% potassium oxalate and 2 mM EDTA, and the
mobile phase chloroform-methanol-4 N NH4OH (45:35:10) (Gonzalez-
Sastre and Folch-Pi, 1968). Radioactive bands were identiﬁed by cochro-
matography of a PIP2 standard. TLC spots were transferred to scintillation
vials, suspended in Cytoscint ES (ICN Biomedicals, Aurora, OH), and
radioactivity determined by liquid scintillation counting (Packard 2000 CA
scintillation counter). A second 20 ml aliquot of the lipid extract was applied
to a piece of silica gel scraped from a blank TLC plate with area similar to the
scraped PIP2 spots, and suspended in Cytoscint ES to determine radio-
activity of the total lipids spotted.
RESULTS
Bradykinin increases intramembrane potential
The potential gradient inside the membrane (intramembrane
potential), which is the sum of contributions from trans-
membrane potential, dipole potential, and the difference in
the surface potentials at both sides of the membrane, was
measured with the 440 nm/530 nm ﬂuorescence ratios of di-
8-ANEPPS. To calibrate the dye, we ﬁrst measured the 440
nm/530 nm ﬂuorescence ratios along the plasma membrane
of a single cell as a function of the applied transmembrane
potential in voltage-clamped N1E-115 neuroblastoma cells
as described by Zhang et al. (1998). We found di-8-ANEPPS
showed linear dependence of ﬂuorescence ratio on potential
with a slope of 113% per 100 mV (data not shown). To
monitor the effect of bradykinin on intramembrane potential,
we took a pair of ﬂuorescence images every 10 s at the
excitation wavelengths of 440 and 530 nm after addition of
bradykinin. The correspondent ratios were normalized to the
baseline ﬂuorescence ratios taken before the addition of
bradykinin to avoid cell-to-cell variation. We expressed the
ratio change as a change in intramembrane potential, cal-
culated as: DVIM¼ (R R0)/R03 100%/13%, where R is the
440/530 nm ﬂuorescence ratio at different times after
bradykinin and R0 is the baseline ﬂuorescence ratio in the
absence of bradykinin. The intramembrane potential, cal-
culated in this way, corresponds to the transmembrane
potential change that would be required to produce the
observed change in ratio. Note that the dye fundamentally
measures the electric ﬁeld at its site in the membrane. It does
not measure a true potential difference between its location
and the extracellular ground.
When stimulated with a saturating concentration of brady-
kinin (1 mM), N1E-115 neuroblastomas showed a highly
reproducible change in the ﬂuorescence ratio of di-8-
ANEPPS, which was characterized by an increase that
returned to baseline even in the continued presence of
bradykinin; the average peak increase in the ratio was 10.96
0.5% with a time to peak of 158.26 4.4 s (n¼ 11) (Fig. 1). If
this ratio change were solely due to a change in trans-
membrane potential, it would be equivalent to a depolari-
zation of 83.5 6 4.0 mV. During our recording period, no
apparent phototoxicity was observed, and there was no
signiﬁcant change in ﬂuorescence ratio in the EBSS control
group across time (P[ 0.05, n ¼ 5; Fig. 1). Fig. 2 shows
a typical recording of changes in intramembrane potential
induced by bradykinin on an individual cell. Consistent with
earlier studies (Zhang et al., 1998), we can see that the
intramembrane electric ﬁeld is heterogeneous along the cell
surface; in Fig. 2, for example, a persistently higher than
average ratio can be found in the membrane patch centered at
3 o’clock. Comparison between the changes in intramem-
brane potential along the whole cell and along the high ratio
area reveals no signiﬁcant difference (Fig. 2, B and C).
Bradykinin inhibits M current and depolarizes
the membrane
The change in intramembrane electric ﬁeld may arise from
changes in transmembrane potentials, surface potentials, and
dipole potentials. Bradykinin has been reported to be able to
inhibit IK(M) (Higashida and Brown, 1987) and depolarize
FIGURE 1 Fluorescence ratios of N1E-115 neuroblastoma cells in
response to bradykinin. At time ¼ 0, 1 mM bradykinin or EBSS was
externally applied to the bathing medium of a cell stained with di-8-
ANEPPS. The 440 nm/530 nm ﬂuorescence ratios were collected with
a cooled CCD camera. The relative change in ratio (left Y axis) and the
calculated change in intramembrane potential as an equivalent of trans-
membrane potential (right Y axis) versus time were plotted. Each point is the
mean6 SE of bradykinin-treated (ﬁlled circle, n¼ 11) or EBSS-treated cells
(empty circle, n ¼ 5).
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the membrane in N1E-115 neuroblastoma cells (Tertoolen
et al., 1987). To test to what extent the depolarization of
transmembrane potential may contribute to the observed
change in intramembrane potential, we monitored the
transmembrane potential on N1E-115 cells under whole cell
current clamp. Tertoolen et al. (1987) reported that addi-
tion of bradykinin (2 mM) to N1E-115 cells induced an
immediate hyperpolarization (10–15 s) followed by a de-
polarization of the membrane (5–10 mV, lasts for a few
minutes) in all the cells tested using conventional electro-
physiological techniques. The transient hyperpolarization
was caused by activation of IK(Ca) (Tertoolen et al., 1987;
Higashida and Brown, 1987). IK(Ca) was inhibited by
intracellular Mg21 and could only be recorded reliably by
using citrate but not acetate as the anion in the pipette, due to
its high buffering capacity for intracellular Mg21 (Robbins
et al., 1992). In our patch-clamp experiments, 3 mM MgCl2
were included and acetate was used as the anion in the
pipette solution. As a result, we found that under current
clamp, addition of bradykinin (1 mM) caused only a slow
depolarization of the membrane potential of 7.2 6 0.9 mV
(n ¼ 9) that lasted for a few minutes without apparent
immediate hyperpolarization. The time to peak for bradyki-
nin-induced depolarization ranges from 62 to 220 s (Fig. 3 A,
panel a and c), with an average of 140.6 6 17.6 s (n ¼ 9).
This is not signiﬁcantly different than the time to peak for
intramembrane potential modulation (158.2 6 4.4 s; Fig. 1).
The depolarization was associated with decreased con-
ductance, as monitored by the voltage response to transient
hyperpolarizing current injections (0.15 nA) (Fig. 3 A, panel
a). Under voltage clamp, we recorded an M-like current in
N1E-115 cells, which is characterized by slow inward
relaxations during membrane hyperpolarization, (Fig. 3 B,
panel a). After addition of bradykinin, these relaxations
were reduced (Fig. 3 B, panel b), consistent with an in-
hibition of the outward current. Current-voltage curves
(Fig. 3 B, panel c) showed that bradykinin inhibits a normal
outward rectiﬁcation current recorded at potentials positive
to 60 mV, with little effect on the current recorded at
potentials negative to 60 mV. These results are compatible
with the view that inhibition of the voltage-dependent IK(M)
accounts for the reduction of conductance and depolarization
induced by bradykinin in N1E-115 neuroblastoma cells
(Higashida and Brown, 1987). Therefore, the similar time to
peak between the bradykinin-induced depolarization and
intramembrane potential modulation suggests that M current
inhibition and intramembrane potential modulation may
be related.
FIGURE 2 Bradykinin increases the intra-
membrane potential along the surface of a single
N1E-115 neuroblastoma cells. (A) The intra-
membrane potential along the surface of the cell,
measured by the pseudocolored 440 nm/530 nm
ﬂuorescence ratios, increases to a peak at 160 s
and decays to baseline in the continued presence
of bradykinin. (B) The 440 nm/530 nm ﬂuo-
rescence ratio of the whole cell (*) and of high
ratio area (framed area in panel A, 1) versus
time. (C) The relative change in ratio (left Y axis)
and the calculated change in intramembrane
potential as an equivalent of transmembrane
potential (right Y axis) for the whole cell (*) and
the high ratio area (ﬁlled 1) versus time.
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Because the peak value of bradykinin induced-depolar-
ization of the transmembrane potential was only;7 mV, the
major portion of the measured increase in intramembrane
potential, namely 83mV as measured by the dye ratio, must
have additional origins such as surface potential or/and
dipole potential. It has been shown that N1E-115 neuro-
blastoma cells respond to bradykinin with an increase in
[Ca21]i (Coggan and Thompson, 1995; Fink et al., 1999,
2000); an increase in [Ca21]i may also change the surface
potential at the inner cell surface by screening and binding to
the negative charges (McLaughlin et al., 1981). Therefore,
we sought to determine whether changes in intramembrane
electric potential are due to an increase in [Ca21]i by
monitoring intramembrane potentials with di-8-ANEPPS
and intracellular Ca21 changes with Calcium Green-1-AM
simultaneously.
FIGURE 3 Effect of bradykinin (1 mM, added at arrow) on M-like current in N1E-115 neuroblastoma cell. (A) Membrane potential change induced by
bradykinin (1 mM) in an untreated cell (panel a) and U-73122 pretreated cell (panel b). Membrane potential was recorded by whole-cell current clamp, and
membrane resistance was monitored by the voltage response to brief hyperpolarizing current injections (0.15 nA). Average resting membrane potential of N1E-
115 cells is37.06 2.2 mV (n¼ 9) for untreated cells,30.76 2.4 mV (n¼ 8) for U-73122 pretreated cells, and29.26 6.6 mV (n¼ 5) for neomycin. (c)
The change in membrane potential, expressed as the measured membrane potential minus the baseline membrane potential, for the cell in panel A, a (open
circle), and for the cell in panel A, b (closed circle), versus time are plotted. Bradykinin (1 mM) was added at time 0. (d) The PLC inhibitors blocks BK-induced
membrane depolarization. Mean 6 SE modulation of transmembrane potential by bradykinin (1 mM), control vehicle (EBSS) (n ¼ 9), or bradykinin after
pretreatment with U-73122 (n ¼ 8) and neomycin (n ¼ 5) are plotted. Bradykinin induced signiﬁcant (P\0.01, **) membrane depolarization in unpretreated
cells, which was abolished by pretreatment with U-73122 and neomycin. (B) Leak-subtracted current responses of another voltage-clamped cell. The cell was
clamped at30 mV and stepped to70 mV and 0 mV for 1 s before (panel a) and after (panel b) addition of bradykinin (1 mM). The graph in panel B, c shows
the absolute current level attained at the end of each voltage step (ordinates, nA) plotted against the command potential (abscissae, mV) before (open circle) and
after (closed circle) addition of bradykinin.
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Bradykinin raises [Ca21]i and increases
intramembrane potential in the
same N1E-115 cells
Consistent with the results of Fink et al (1999, 2000), we
found that saturating concentrations of Bradykinin (1 mM)
induced a rapid spikelike increase in [Ca21]i that decays to
basal levels within 70 s of stimulation (Fig. 4). The calcium
increase is observed within 6 s, with peak ﬂuorescence
increase approximating 20% (20.0 6 2.14%, n ¼ 11),
occurring 8–10 s after the addition of bradykinin.
Dual wavelength ratiometric imaging of di-8-ANEPPS in
the membrane and ﬂuorescence imaging of Calcium Green
in the cytosol were also performed simultaneously. Fig. 4
shows that in the eight cells that showed signiﬁcant increase
in [Ca21]i, bradykinin raises Calcium Green ﬂuorescence by
;20% (19.86 3.4%, n ¼ 8) with time to peak of;10 s and
a return to baseline within 70 s. However, in the same
population of cells, the intramembrane potential reaches
peak (11.1 6 0.8%, n ¼ 8) 150 s after the addition of
bradykinin and returns to baseline within 300 s. Although the
increase in intracellular calcium concentration should screen
surface charge along the inner surface of the cell, thereby
increasing the intramembrane potential, the distinct differ-
ence in the time course of these two effects indicates that
a rise in [Ca21]i cannot be directly responsible for the
dramatic increase in intramembrane potential induced by
bradykinin. Furthermore, Fink et al. (1999, 2000) showed
that the resting [Ca21]i in N1E-115 neuroblastoma cells is
around 50 nM, and a saturating dose of bradykinin increases
[Ca21]i to 1200 nM. Using the Gouy-Chapman-Stern theory
elaborated by McLaughlin et al. (1981), if we assume the net
negative charge density at the inner surface of the membrane
is 0.14 e/nm2 (Chandler et al., 1965), such an increase in
the cytosolic Ca21 concentration would cause a change in
surface potential at the inner membrane surface of\0.1 mV.
This is further indication that [Ca21]i cannot contribute
directly to the observed change in intramembrane potential.
However, it is quite possible that the calcium signal and the
intramembrane potential change share portions of the same
pathway.
It is noteworthy that even using saturating concentrations
of BK, not all the N1E-115 cells were responsive. The
calcium levels did not change in three out of 16 cells (19%)
challenged with bradykinin, possibly due to inadequate
receptor density. This percentage of nonresponsive cells is
similar to our earlier report (Fink et al., 1999, 2000). We
believe this provides a good internal control to explore
whether bradykinin-induced calcium response shares the
same pathway as the increase in intramembrane potential.
We did ﬁnd that there was a signiﬁcant correlation between
the calcium response amplitude and the peak intramembrane
potential responses to bradykinin (Fig. 5). The linear
regression analysis of the data in Fig. 5 indicates there is
a signiﬁcant (P \ 0.01) direct linear correlation between
the changes in intramembrane potential and [Ca21]i, with
a correlation coefﬁcient (r) of 0.787. Most noteworthy,
however, the three cells in Fig. 5 that did not respond to
bradykinin with a strong increase in [Ca21]i also did not
FIGURE 4 Effects of bradykinin on modulating intracellular Ca and
intramembrane potentials in the responding N1E-115 cells. At time ¼ 0, 1
mM bradykinin was externally applied to the bathing medium of the cells
stained with both Calcium Green-1-AM (CG-1) and di-8-ANEPPS. Calcium
Green ﬂuorescence (dashed curve) and ﬂuorescence ratios of di-8-ANEPPS
(solid curve) recorded simultaneously were plotted versus time. Each data
point represents the mean 6 SE of the eight cells that showed signiﬁcant
response to bradykinin.
FIGURE 5 Correlation between the relative change in intramembrane
potential and the increase in Calcium Green ﬂuorescence induced by
bradykinin. The relative change in Calcium Green ﬂuorescence at 10 s was
plotted versus the relative change in the 440 nm/530 nm ﬂuorescence ratio of
di-8-ANEPPS at 150 s after the addition of bradykinin (1 mM). A correlation
coefﬁcient (r) of 0.70 was obtained by correlation analysis (P\0.05). Data
were obtained from 14 cells that were double stained with di-8-ANEPPS and
Calcium Green-1-AM and then treated with 1 mM bradykinin at time ¼ 0.
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respond with an increase in intramembrane potential. These
results suggest that these two effects may share at least part
of the same signal pathway. The [Ca21]i elevation in N1E-
115 neuroblastoma cells in response to bradykinin is me-
diated by the B2 receptor. This calcium response arises
exclusively from IP3-dependent release of calcium from
endoplasmic reticulum (ER) stores, since its amplitude is not
dependent upon extracellular calcium (Iredale et al., 1992;
Coggan and Thompson, 1995) or the activation of ryanodine
receptors in the ER (Wang and Thompson, 1995). Thus,
even though the time courses are different, the close cor-
relation between the changes in intramembrane potential
and [Ca21]i suggests that the bradykinin-induced increase
in intramembrane potential is probably mediated by B2 re-
ceptors and requires activation of PLC.
PLC inhibitors block bradykinin modulation
of intramembrane potential and
transmembrane potential
To test whether the bradykinin-induced increase in intra-
membrane potential needs activation of PLC, we pretreated
the N1E-115 neuroblastoma cells with two different PLC
inhibitors, neomycin (500 mM) or U-73122 (1 mM). Neo-
mycin can reduce IP3 formation by binding to phospho-
inositides (Slivka and Insel, 1988). Pretreatment with 1 mM
U-73122 has been shown to block bradykinin-induced Ca21
transients in dorsal root ganglion neurons and NG108-15
cells (Jin et al., 1994) and bradykinin-inhibition of IK(M) in
dorsal root ganglion neurons (Cruzblanca et al., 1998). We
also used U-73343, an inactive analog of U-73122, as
a control. In our experiments, N1E-115 neuroblastoma cells
were preincubated with the PLC inhibitors or EBSS solution
(as control) for 30 min before the addition of bradykinin. The
peak changes in intramembrane potential as measured by dye
ratio after addition of bradykinin in different cell groups are
summarized in Fig. 6. The bradykinin-induced increase in
dye ratio (i.e., intramembrane potential) is signiﬁcantly
lower in cells treated with U-73122 (1.06 0.32%, n¼ 12) or
neomycin (0.93 6 0.56%, n ¼ 8), compared to control cells
(7.73 6 4.71%, n ¼ 17) (P\ 0.01) or cells treated with
U-73343 (4.97 6 1.43%, n ¼ 11) (P\ 0.01). There was
no signiﬁcant difference between bradykinin modulations of
intramembrane potential in U-73343-treated neuroblastomas
and control neuroblastoma cells (P[ 0.05). The fact that
the PLC inhibitors block bradykinin-induced increase in in-
tramembrane potential, whereas the inactive U compound
U-73343 has no effect, suggests bradykinin modulation of
intramembrane potential involves activation of PLC.
The effect of U-73122 and neomycin on transmembrane
potential is summarized in Fig. 3 A, panel d. We compared
the effect of bradykinin on untreated neuroblastoma cells and
PLC inhibitor-pretreated neuroblastoma cells. Before the
addition of bradykinin (1 mM), there was no signiﬁcant
difference between resting potential in the EBSS control
group (33.0 6 2.0 mV, n ¼ 5) versus the U-73122 group
(30.76 2.4 mV, n¼ 8) and the neomycin group (29.26
6.6 mV, n ¼ 5). However, the bradykinin-induced de-
polarization was abolished in the U-73122 group (0.1 6
0.3 mV, n¼ 8) or the neomycin group (0.86 0.8 mV, n¼
5), compared to the cells treated only with bradykinin (7.26
0.9 mV, n ¼ 9) (Fig. 3 B). At the same time, the bradykinin-
induced decrease in membrane conductance was abolished
by pretreatment with PLC inhibitor (Fig. 3 A, panel b).
Higashida and Brown (1987) have demonstrated that the
bradykinin-induced decrease in conductance was due pri-
marily to inhibition of the M current. Taken together, there
is a strong parallel between the responses of IK(M) and the
intramembrane electric ﬁeld to activation of the B2 brady-
kinin receptorwith respect to both pharmacology andkinetics.
PIP2 composition of N1E-115 cell membrane
The ﬁnding that PLC inhibitors blocked the bradykinin
modulation of intramembrane potential suggests an in-
volvement of hydrolysis of membrane PIP2. To examine the
relative content of PIP2 in the cell membrane, cells were
labeled to equilibrium with 32P-PO4
2. We used a thin layer
chromatography system to resolve PIP2 from the other
phosphoinositides (phosphatidylinositol, phosphatidylinosi-
tol 4-phosphate) and all other plasma membrane phospho-
lipids (Gonzalez-Sastre and Folch-Pi, 1968). The identity of
FIGURE 6 The PLC inhibitors block BK-induced increase in intra-
membrane potential. Mean6 SE modulation of di-8-ANEPPS ﬂuorescence
ratio and corresponding intramembrane potential by bradykinin (1 mM)
in neuroblastoma cells treated with EBSS (n ¼ 15), U-73343 (n ¼ 11),
U-73122 (n ¼ 10), or neomycin (n ¼ 8) is plotted. The BK-mediated in-
crease in ratio is signiﬁcantly lower in cells treated with U-73122 and neo-
mycin than in control EBSS treated cells (P\ 0.01, **).
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PIP2 was also veriﬁed by cochromatographing unlabeled
authentic PIP2 standards and visualizing them with phos-
phomolybdic acid. Our data showed that PIP2 comprised
0.43 6 0.02% of total cellular phospholipids. Application
of a simpliﬁed version of the Gouy-Chapman theory
(McLaughlin et al., 1981, but see a more thorough analysis
in the Discussion section) suggests that even if all the PIP2,
each contributing three negative charges, were depleted from
the inner membrane by hydrolysis to DAG and IP3, this
could account for no more than 4 mV of the change in
intramembrane potential. We therefore explored the contri-
bution of a change in dipole potential to the overall change in
intramembrane potential.
DAG increases intramembrane potential
in both phosphatidylcholine and
phosphatidylserine vesicles
It has been shown that the dipole potential of a DAG
monolayer is signiﬁcantly higher than that of a phosphatidy-
linositol monolayer (Smaby and Brockman, 1990). In the
next experiment, we examined whether DAG could change
intramembrane potential in lipid bilayers using voltage
sensitive dye di-4-ANEPPS. We switched to di-4-ANEPPS
for these experiments because the voltage sensitivity of this
dye has been better characterized and fully calibrated in lipid
vesicles (Montana et al., 1989), whereas no such prior work
has been done with di-8-ANEPPS. We measured the effect
of incorporating 10% DAG on the excitation spectra of di-4-
ANEPPS in both PC and PS vesicles. Addition of DAG
shifts the excitation spectra of di-4-ANEPPS for both lipids.
The lipid-bound dye has an excitation maximum at 468 nm
in PC vesicles, 466 nm in PC:DAG vesicles, 472 nm in PS
vesicles, and 469 nm in PS:DAG vesicles. By normalizing
the areas of the excitation spectra obtained in the presence of
DAG to the integrated intensity obtained in the absence of
DAG, we found that in PS vesicles, the maximum positive
and negative changes in excitation spectrum induced by
DAG occur at the wavelengths 440 nm and 505 nm, re-
spectively (Fig. 7). DAG induced similar change in the ex-
citation spectra of di-4-ANEPPS bound to PC vesicles, but of
smaller amplitude (data not shown). Montana et al. (1989)
found that the ratio of di-4-ANEPPS ﬂuorescence excited at
440 and 505 nm has a linear relationship to transmembrane
potential with a slope of 9%/100 mV. To determine the
change in intramembrane potential induced by DAG, the
ratio of ﬂuorescence excited by these two wavelengths was
recorded, and the change in intramembrane potential (DVIM)
induced by DAG was calculated as: DVIM ¼ (R  R0)/R0 3
100 mV/0.09, where R was the 440/505 nm ﬂuorescence
ratio for DAG incorporated vesicles and R0 was the
ﬂuorescence ratio in the absence of DAG. We found the
ﬂuorescence ratios for PC, PC:DAG, PS, and PS:DAG were
1.59 6 0.01 (n ¼ 3), 1.61 6 0.01 (n ¼ 6), 1.33 6 0.01 (n ¼
11), and 1.39 6 0.00 (n ¼ 12), respectively. Compared to
pure PC vesicles, 10% DAG increased intramembrane
potential of 27.2 6 4.4 mV in PC:DAG vesicles. Compared
to pure PS vesicles, 10% DAG increased intramembrane
potential of 49.5 6 2.7 mV in PS:DAG vesicles.
Parenthetically, there was also a signiﬁcant difference
(169.5 6 6.2 mV) in intramembrane potential between pure
PC and PS vesicles. It should be mentioned that in both PC
and PS vesicles, the surface potentials at the inner and outer
surfaces are symmetrical. Therefore the difference between
internal and external surface potentials does not contribute to
intramembrane potential, and the difference in intramem-
brane potential between PC and PS vesicles is due to
a difference in dipole potential. Our result is consistent with
the ﬁnding that the dipole potential of a PC monolayer is
;132 mV higher than that of a PS monolayer (Brockman,
1994), further validating the application of the dual wave-
length ﬂuorescence ratio for the measurement of dipole
potential.
DISCUSSION
We have provided evidence that activation of PLC can
dramatically change intramembrane potential and that
voltage-sensitive dyes can be used to monitor these dynamic
changes in single cells. Bradykinin elicited an increase in
intramembrane potential in N1E-115 neuroblastoma cells by
an amount equivalent to a depolarization of 83 mV. The time
course for this increase in intramembrane potential is similar
to the change in transmembrane potential associated with
BK-mediated inhibition of IK(M); however, the latter in-
creased only 7.2 6 0.9 mV. The BK-induced release of
calcium from the ER in these cells has been thoroughly
studied and is known to involve, in turn, activation of PLC,
hydrolysis of PIP2 to form IP3 and DAG, and the activation
FIGURE 7 DAG induces wavelength shifts revealed by normalized
difference spectra of PS lipid vesicles containing 0.2 mM di-4-ANEPPS.
The plot represents the difference in the normalized excitation spectrum of
pure PS vesicles and vesicles composed of 9:1 PS:DAG; the emission
wavelength is 610 nm.
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of IP3 receptor calcium channels in the ER. The increase in
intramembrane potential is likely to also require activation of
PLC, because we determined that: i), it is not found in the
minor group of cells that do not display Ca21 release; ii), its
amplitude was signiﬁcantly correlated with the amplitude
of [Ca21]i elevation; and (iii), it was blocked by the PLC
inhibitors U-73122 and neomycin. This Discussion will ex-
plore the possible biophysical origins of the change in intra-
membrane potential and its role in the modulation of IK(M).
The intramembrane potential is comprised of transmem-
brane potential, the difference between internal and external
surface potential, and the internal and external dipole
potential. The potential proﬁle within the cell membrane
can be derived from the sum of the potential proﬁles due to
each of these contributions. In interpreting the dye signal, it
is important to keep in mind that the ratio is fundamentally
sensitive to the potential gradient (i.e., electric ﬁeld) at its
location rather than the actual value of potential relative to
some distant arbitrary ground. First, from current-clamp
measurement of membrane potential, we know that the
measured 83 mV increase in intramembrane potential in-
duced by bradykinin has only a minor contribution, 7 mV,
from transmembrane depolarization. The remaining increase
in intramembrane potential (;76 mV) may have signiﬁcant
contributions from changes in surface potential and dipole
potential caused by the loss of PIP2 and its replacement
DAG. The second source of intramembrane potential is
surface potential. Considering that the membrane loses ;3
negative charges for every PIP2 that is hydrolyzed upon
bradykinin-induced PLC activation, the increase in intra-
membrane potential may be partially explained by a de-
creased surface potential at the inner side of the plasma
membrane. Thin layer chromatography analysis of the 32P
incorporation into the cellular lipids showed that PIP2
comprised 0.43% of the total cellular phospholipids, which
consist of phospholipids from both plasma membrane and
intracellular membranes including endosomes, endoplasmic
reticulum, lysosomes, mitochondria, nucleus, and Golgi. It
has been found that;50% of total cellular phospholipids are
present in the plasma membrane of cultured cells (Warnock
et al., 1993; Lange et al., 1989). Additionally, it has been
found that ;40% of total cellular PIP2 are present in the
plasma membrane of cultured cells (Watt et al., 2002).
Taking these factors into consideration, the basal level of
PIP2 comprises ;0.3% of phospholipids in the plasma
membrane in our neuroblastoma cells. Furthermore, the
percentage content of PIP2 relative to the phospholipids in
the inner leaﬂet of the plasma membrane would be 0.5%,
since 80% of PIP2 are found in the inner leaﬂet of the plasma
membrane. Using the Gouy-Chapman-Stern theory (Chan-
dler et al., 1965; Gilbert and Ehrenstein, 1969; McLaughlin
et al., 1981), we can estimate the changes in surface potential
at inner surface of the membrane after hydrolysis of all these
PIP2 molecules. If we assume the free negative charge
density for the inner surface of the membrane is 0.14 e/nm2
(Chandler et al., 1965), hydrolysis of such an amount of PIP2
in the inner leaﬂet should lead to an increase in internal
surface potential of;4 mV (i.e., from 24 mV to20 mV).
Similarly, as described in the Results, the change in Ca21 is
too small to signiﬁcantly screen the internal surface charge
and is in any case too fast to account for the change in
intramembrane potential. Therefore, the major portion of the
increase in intramembrane potential cannot be attributed to
obvious mechanisms for modulation of surface potential.
The third source of intramembrane potential that must
be considered is the dipole potential. The dual wavelength
ﬂuorescence ratio of di-8-ANEPPS has been shown to be
particularly sensitive to dipole potential because the sensor
chromophore is situated just within the membrane where the
electric ﬁeld set up by this potential is most intense (Gross
et al., 1994). Most relevant here is an earlier monolayer study
showing a striking dipole potential difference between
monolayers containing phosphatidylinositol and monolayers
containing its PLC mediated hydrolysis product, DAG
(Smaby and Brockman 1990). In this study we measured
the effect of 10% DAG on intramembrane potential in PC
and PS vesicles. DAG increased intramembrane potential in
both PC (27 mV) and PS vesicles (49 mV). Therefore, one
might expect that generation of DAG from hydrolysis of
PIP2 at the inner leaﬂet of the plasma membrane could
produce a large increase in dipole potential. But will a dye
probe that is situated on the outer leaﬂet of the membrane be
sensitive to a dipole potential change associated with the
inner leaﬂet? The region of largest electric ﬁeld (i.e., the
steepest potential gradient) associated with dipole potential
occurs within a few A˚ of the membrane surface, so the dye
ratio will be much more sensitive to a change in lipid
composition in its own leaﬂet of the bilayer (Gross et al.,
1994). This might be expected from an equilibration of DAG
across the membrane because it is known to have an ex-
traordinarily high rate of spontaneous ﬂipping—in lipid
vesicles, the time constant for DAG equilibration across the
bilayer is 70 ms compared to hours for phospholipids (Bai
and Pagano, 1997). Our analysis of the IP3 production
necessary to evoke the observed calcium signals after sat-
urating bradykinin (Fink et al., 2000) indicates that newly
formed DAG reaches a level of 12,560 molcules/mm2, or
;0.9% of the internal membrane (this is similar to the initial
concentration of PIP2, but could also reﬂect some resynthesis
of PIP2 as a consequence of BK stimulation (Xu et al., 2003).
Given that 10% DAG produces a dipole potential change of
30–40 mV in lipid vesicles, 0.9% DAG is still, therefore,
insufﬁcient to explain the observed BK-induced change in
the neuroblastoma cell di-8-ANEPPS ﬂuorescence ratio.
However, it has been reported that in both a dorsal root
ganglion 3 neurotumor hybrid cell line F11 (Francel and
Dawson, 1988) and ﬁbroblasts (van Blitterswijk et al., 1991;
Fu et al., 1992), bradykinin induces a biphasic increase in
DAG, with an initial rapid, transient peak followed by a more
slowly developing accumulation that increases cellular DAG
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level up to three- to fourfold. The ﬁrst peak is caused by PIP2
hydrolysis and is accompanied by an increase in IP3 and
[Ca21]i. The second increase reaches its peak after minutes
and comes from hydrolysis of PC, by the phospholipase C
that acts on PC (PC-PLC), or by the concerted action of
phospholipase D (PLD) and phosphatidate phosphohydro-
lase (van Blitterswijk et al., 1991). The activation of PC-PLC
and PLD in many cases is thought to follow the PKC
activation by DAG originating from the initial hydrolysis of
PIP2 (Exton, 1994). In N1E-115 cells, therefore, activation
of PLC by bradykinin could induce the subsequent activation
of PC-PLC and/or PLD to generate substantial DAG in
a prolonged phase, thereby producing a large change in
intramembrane potential. Additional support for this sce-
nario can be found in many published studies, e.g.:
1. It has been found that in NG108-15 cell line, bradykinin
induces both generation of DAG from hydrolysis of PIP2
(Yano et al., 1985) and a sustained increase in non-PIP2
derived-DAG (Brami et al., 1991).
2. Bradykinin activates PLD in PC12 cells (Purkiss et al.,
1991).
3. Dimethylsulfoxide induces a biphasic increase in DAG
levels in N1E-115 cells (Clejan et al., 1996), with an ini-
tial rapid, transient peak followed by a slowly developing
accumulation that increases cellular DAG level up to
twofold; the ﬁrst phase of DAG is generated through
PIP2 hydrolysis, whereas the second phase of DAG is
generated through PC-PLC-mediated hydrolysis of PC.
This result demonstrates that the coupling mechanism
between hydrolysis of PIP2 and activation of PC-PLC
exists in N1E-115 cells.
4. There is a high basal level of DAG in N1E-115 neuro-
blastoma cells (1300 pmol/mg protein) (Clejan et al.,
1996). Generally, neuroblastoma cells tend to have a high
basal level of DAG. For example, the basal level of DAG
is 2000 pmol/mg protein in NG 108-15 cells (Brami et al.,
1991), 1500 pmol/mg protein in human SK-N-SH cells
(Lee et al., 1991), and comprises 2.2% of cellular phos-
pholipids in mouse NB41A3 cells (Yorek et al., 1994).
A typical differentiated N1E-115 cell used in our experi-
ments has a diameter of 40 mm, and 400 pg protein.
Assuming the molecular area of a phospholipid is 70 A˚2, the
basal DAG would comprise ;4% of cellular lipids. If
bradykinin-induced hydrolysis of PIP2 did activate PC-PLC
(or PLD) and induced subsequent increase in DAG up to
threefold, that could produce an increase in DAG from;4%
to 12% of cell lipids. That could be sufﬁcient to account for
the observed increase in intramembrane potential, especially
if we also consider the possibility of lipid domains that are
enriched in both dye and DAG. Thus, only 15–20 mV of the
observed change in intramembrane potential could arise
from the measured change in transmembrane potential and
the inferred changes in surface and dipole potential due to
hydrolysis of PIP2 to DAG; the remaining ;60 mV could
arise from the dipole potential changes induced by the
subsequent hydrolysis of PC to form DAG.
Bradykinin also produces two membrane current changes
when applied to N1E-115 mouse neuroblastoma cells
(Higashida and Brown, 1987), rat pheochromocytoma
PC12 cells (Villarroel et al., 1989), and NG 108-15 cells
(Brown and Higashida, 1988; Robbins et al., 1993). It
activates a transient Ca21-dependent K1 conductance that is
associated with an increase in intracellular calcium; and it
inhibits an M-type voltage-dependent K1 current (IK(M)) that
develops more slowly and lasts for minutes. The M current
(IK(M)) is a time- and voltage-dependent K
1 current activated
over the range 70 mV–0 mV. It plays an important role in
regulating cell membrane excitability by stabilizing the
resting membrane potential. M current inhibition by brady-
kinin is mediated by a pertussis toxin-insensitive G-protein
(Villarroel, 1996), speciﬁcally by Gaq and/or Ga11 (Jones
et al., 1995) that activates PLC.
Whereas Cruzblanca et al. (1998) showed that bradykinin
used intracellular Ca21 as second messenger to inhibit IK(M)
in rat sympathetic neurons, the mechanism underlying
bradykinin suppression of IK(M) in N1E-115 neuroblastoma
cells, PC12 cells, and NG 108-15 cells remains unclear. It
seems that Ca and IP3 are not likely to be the ‘‘messenger’’,
since in these cells i), inhibition of IK(M) persists when the
release of Ca and /or activation of IK(Ca) is suppressed by
buffering internal Ca with BAPTA (Villarroel et al., 1989);
ii), inhibition of IK(M) is not replicated by Ca
21 injection
(Higashida and Brown, 1986); and iii), introduction of IP3
into the cells does not inhibit IK(M) nor does it block the
subsequent inhibition of IK(M) by bradykinin, even though it
does inhibit bradykinin-induced activation of IK(Ca) (Villar-
roel et al., 1989; Higashida and Brown, 1986, 1987; 1988).
Our ﬁnding that the IP3-Ca
21 release event has a much
shorter duration and a much faster onset than M current
inhibition also suggests that Ca21 elevation is not likely to be
directly responsible for M current modulation in N1E-115
neuroblastoma cells, although M current inhibition requires
activation of PLC, since it can be blocked by PLC inhibitors
U-73122 and neomycin.
The dramatic change in the electric potential proﬁle of the
lipid bilayer that occurs after hydrolysis of PIP2 could affect
the voltage-dependence of ion channels including M-type
potassium channels in the membrane. In the present work,
we found that bradykinin reduced the M channel conduc-
tance in a voltage-sensitive manner. In addition, bradykinin
increased intramembrane potential and inhibited IK(M) with
similar kinetics. These results are consistent with the hypo-
thesis that an increase in intramembrane potential, possibly
induced by PC-derived DAG, leads to an inhibition of IK(M)
channels in N1E-115 cells. Indeed, it has been found that
1-oleoyl-2-acetylglycerol, a membrane-permeable DAG
analog (Kaibuchi et al., 1985), mimicked bradykinin-
induced inhibition of IK(M) (Brown and Higashida, 1988).
DAG analogs also directly inhibit cloned voltage-gated
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Shaker IR, Kv1.4, and Kv1.6 potassium channels (Bowlby
and Levitan, 1995), cardiac L-type calcium channels
(Conforti et al., 1995; Schreur and Liu, 1996), and rod
cyclic nucleotide-gated channels (Gordon et al., 1995) with-
out a PKC-dependent phosphorylation reaction. Therefore,
it is possible that the increase in intramembrane potential
is the underlying mechanism for M current inhibition by
bradykinin in these cells.
Finally, it should be noted that an increased intra-
membrane potential would not necessarily affect all the ion
channels that reside in the membrane to the same extent. This
is because the primary contribution to the measured change
in intramembrane potential likely arises from an increase in
dipole potentials, which are localized to an ;5 A˚ thick
region within the plasmalemma just below the lipid-aqueous
interface. The gating sensors of different ion channels could
be experiencing very different electric ﬁelds depending on
whether they are located in this region.
In summary, we have shown that BK-mediated activation
of PLC induces an increase in intramembrane potential in
neurons. The increase in intramembrane potential has minor
contributions from: a depolarized transmembrane potential;
an increased surface potential at the inner surface, as the
negatively charged PIP2 is depleted; and an increased dipole
potential, as PIP2 is hydrolyzed to diacylglycerol. Its major
contribution, we hypothesized, is an increased dipole
potential produced by PC-derived DAG, as PC is hydrolyzed
by PC-PLC or PLD after activation of PLC. This increase in
intramembrane potential could be an underlying mechanism
for M current inhibition by bradykinin, since the two events
have similar kinetics and both can be blocked by PLC
inhibitors.
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